What iNova Pharmaceuticals does

iNova Pharmaceuticals is a Singapore-domiciled, privately held consumer healthcare and prescription medicines company that develops, markets, and distributes a portfolio of over 20 heritage brands across 75+ international markets spanning Asia-Pacific, the Middle East, Africa, Europe, and select North American markets. Its consumer healthcare portfolio is anchored by long-standing brands including BETADINE (povidone-iodine antiseptics), Difflam (throat care), Duro-Tuss (cough), Demazin (cold and flu), DermaVeen (dermatology), and Acne-Aid, alongside regional brands such as Gold Cross, Nyal, Creche Guard, Andolex, B-CAL, Invisible Zinc, and Reef. The prescription medicines portfolio spans weight management (Contrave, Duromine), pain, cardiology, respiratory (Airomir, Qvar, Nuelin), and dermatology (Aldara, Efudix). The company's core technology is consumer healthcare formulation science — proprietary combinations including povidone-iodine antiseptic systems, benzydamine-based anti-inflammatory throat formulations, and therapeutic cough and dermatological preparations — rather than novel drug discovery.

iNova operates a multi-channel go-to-market model: branded OTC products are sold primarily through retail pharmacy chains and independent pharmacies (including named partner Chemist Warehouse in Australia), supported by 13+ regional offices in Singapore (global HQ), Chatswood (Australia), Hong Kong, Kuala Lumpur, Manila, Bangkok, Jakarta, Dubai, Johannesburg, Cairo, Auckland (via Radiant Health subsidiary), Dublin, and Zug. Distribution to healthcare providers for prescription medicines is managed through a regional field sales structure, while brand extension into new markets is supported by licensing partners such as Lavipharm. The business model is straightforward product sale through retail and pharmacy channels, supplemented by in-licensing and brand acquisition as the primary portfolio expansion mechanism. Growth has been largely inorganic: iNova was acquired by Valeant in 2011, by Pacific Equity Partners and Carlyle in 2017, and by TPG (majority), Pacific Equity Partners, and Platinum Orchid/ADIA in 2022, with subsequent add-on acquisitions including Demazin (2019), Radiant Health and Acne-Aid (2020), and the transformational Mundipharma International consumer health portfolio including BETADINE in 2024.

Name

iNova Pharmaceuticals

Legal name

iNova Pharmaceuticals

Website

https://inovapharma.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

251–500 employees

Short description

iNova Pharmaceuticals is a Singapore-domiciled, PE-backed consumer healthcare company that develops, markets, and distributes a portfolio of 20+ heritage OTC and prescription brands including BETADINE, Difflam, Duro-Tuss, and Demazin across 75+ markets in Asia-Pacific, the Middle East, Africa, and Europe, primarily through retail pharmacy and healthcare provider channels.

Ownership category

akta.pro rank

Product category

Consumer Healthcare Pharmaceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industries

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Respiratory & Allergy Pharmaceuticals (HLAIAAAH), Gastroenterology & Hepatology Pharmaceuticals (HLAIAAAI), Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF)

Keywords

• Consumer healthcare products
• Prescription medicines
• Over-the-counter medicines
• Antiseptic wound care
• Throat care remedies

Headquarters

HQ city

Chatswood

HQ country

Australia

HQ region

Oceania

Offices13 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

1. Consumer Healthcare Products: Sale of over-the-counter consumer healthcare products including analgesics, throat/cold remedies, antiseptic wound care, dermatology products, and cough medicines through retail pharmacies across 75+ markets
2. Prescription Medicines: Prescription pharmaceutical products sold through healthcare providers and pharmacies
3. Brand Licensing and Acquisitions: Revenue generated through in-licensing, acquisition, and licensing out of established consumer health brands across global markets

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

iNova Pharmaceuticals develops, markets and distributes a portfolio of trusted branded consumer healthcare products (including wound care antiseptics, throat/cough/cold/flu remedies, dermatology and sun care, natural health supplements, and medicine cabinet essentials) and prescription medicines across weight management, pain management, dermatology, respiratory and cardiology categories. The company sells these products across more than 75 markets via retail pharmacy networks, healthcare providers and brand licensing partners, with an active acquisition and in-licensing strategy to expand its brand portfolio and geographic reach.

Product overview

iNova Pharmaceuticals is a consumer healthcare company offering a broad portfolio of trusted brands across Consumer Healthcare and Prescription Medicines. The Consumer Healthcare portfolio includes: Throat, Cough, Cold & Flu brands (BETADINE, Difflam, DURO-TUSS, Demazin, Valda, Andolex, Dequadin); Wound Care (BETADINE); Skin Health & Sun Protection (DermaVeen, Acne-Aid, Invisible Zinc, Reef); Natural Health supplements (Senokot, Creche Guard, PregOmega Plus, B-CAL, Ferrous Forte, StaminoGro); and Medicine Cabinet Essentials (Nyal, Gold Cross, Hiprex). The Prescription Medicines portfolio spans Weight Management (Contrave, Duromine), Pain Management (various), Heart Health, Dermatology (Aldara, Efudix, ReTreive), and Respiratory Health (Airomir, Qvar, Nuelin). Products are available across 75+ markets globally with regional offices in Asia-Pacific, Middle East, Africa and Europe.

Differentiator

Problem solved

Functional benefit

Brands

• BETADINE: Wound care brand trusted by healthcare professionals worldwide for over 60 years. Products include antiseptic solutions for wound care, sore throat relief, and feminine care.
• Difflam
• Duro-Tuss
• Demazin
• DermaVeen
• Acne-Aid
• Nyal
• Senokot
• Valda
• Gold Cross
• Invisible Zinc
• Reef
• Creche Guard
• Andolex
• Dequadin
• B-CAL
• StaminoGro
• Ferrous Forte
• PregOmega Plus
• Hiprex

Products and services

• BETADINE BETADINE is a trusted antiseptic brand containing povidone-iodine, offering wound care solutions, sore throat relief products, and feminine care products. Available globally in multiple formats including solutions, gargles, sprays, and lozenges, trusted by healthcare professionals worldwide for over 60 years.
• Difflam Difflam is a leading sore throat brand in Asia-Pacific with over 30 years of history, offering lollipops, lozenges, sprays, solutions and gargles for sore throat relief. Products include Difflam Kids Soothing Throat Pops with Wellmune for immune health support.
• DURO-TUSS DURO-TUSS is a trusted cough relief brand for over 25 years in Asia-Pacific, available as syrups, tablets and lozenges for chesty coughs, dry coughs, and children's coughs.
• Demazin Demazin is a trusted cold and flu brand trusted by families for over 50 years in Australia, offering products for colds, coughs, nasal congestion, and hayfever relief with a comprehensive kids range.
• DermaVeen DermaVeen is a dermatologist-recommended skincare brand formulated with 100% natural OatActiv+, offering hypoallergenic body, face, hair, sun and baby products for dry, itchy and sensitive skin.
• Acne-Aid Acne-Aid offers a range of effective products for oily and acne-prone skin including cleansers, lotions and remedies targeting oil control and sensitive skin. Trusted across Asia with 99% user recommendation rate.
• Nyal Nyal is a family favourite medicine cabinet brand trusted since 1911, providing medicines for pain relief, coughs, cold and flu, nasal congestion and mouth health in Australia.
• Senokot Senokot is a gentle laxative made from senna plant leaves and fruit, providing overnight relief from occasional constipation for over 60 years.
• Valda Valda offers pastilles and hard candy for throat relief with a mega-hit of menthol, available in Original Lemon, Lemon Menthol, Citrus Menthol and Himalayan Salt and Lemon Menthol flavors.
• Gold Cross Gold Cross is a respected pharmacy-only brand trusted for over 70 years, providing medicines for coughs, colds, skin irritations, cuts, abrasions, digestive complaints, muscle and joint relief, and vitamin supplementation.
• PregOmega Plus PregOmega Plus is South Africa's number one prenatal 3-in-1 combination supplement containing Folate, Calcium, Iron, B-vitamins, Vitamin D, Vitamin A and Omega 3 for before, during and after pregnancy.
• Creche Guard Creche Guard is South Africa's Number 1 Children's Multivitamin and Mineral Supplement offering Immune Multivitamin products with Zinc, Vitamin D and Vitamin C, and a Probiotic range including oral sprays, drops, and chocolate bars.
• Andolex Andolex is South Africa's leading brand for sore throat and mouth, offering throat sprays, sore throat lozenges, dry mouth pastilles, throat lollies, oral rinses and oral gel with anti-bacterial and antiseptic properties.
• Dequadin Dequadin is a medicated sore throat relief brand that effectively kills germs and soothes the throat, with a non-medicated range delivering refreshment with menthol.
• B-CAL B-CAL is South Africa's No. 1 prescribed and best-selling calcium range offering bone health supplements including B-CAL-K2 (5-in-1 with Calcium, Vitamin D3, Magnesium, Vitamin K2, Vitamin C) and B-CAL-DM.
• Ferrous Forte Ferrous Forte is a combination iron supplement containing iron bisglycinate for better absorption with Folic Acid, Vitamin B12, and Vitamin C to help form healthy red blood cells and hemoglobin.
• StaminoGro StaminoGro is a 5-in-1 combination supplement with amino acids, antioxidants, B-vitamins, Calcium and other vitamins and minerals to promote energy, well-being, immune defence and mental vitality. Includes StaminoGro Woman variant with added Iron and Folic Acid.
• Hiprex Hiprex is used for prevention or suppression of bacteria in the urine that can cause chronic or recurrent urinary tract infections (UTIs).
• Invisible Zinc Invisible Zinc is Australia's leading zinc sunscreen brand offering broad range of high SPF products using naturally sourced Zinc Oxide to create a physical barrier reflecting UVA and UVB rays.
• Reef Reef is one of Australia's most iconic sun care brands since the 1970s, featuring coconut scented skincare oils and SPF suncare products formulated with Almond Oil and Coconut Oil.
• Prescription Medicines Portfolio iNova offers prescription medicines across cardiology, pain management, weight management, allergy, dermatology and respiratory health including Airomir, Aldara, Contrave, Duromine, Efudix, Lomotil, Maxolon, Nuelin, Qvar, Rikodeine, and others.

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core, major and minor.

• LavipharmcoreStrategic or Co-development PartnerStrategic agreement with Lavipharm for brand development and distribution partnership, leveraging Lavipharm's regional pharmaceutical expertise and distribution capabilities.
• Chemist WarehousemajorChannel Partner/ Reseller/ DistributorChemist Warehouse is a major retail pharmacy partner for iNova products in Australia, including participation in blister pack recycling initiative with Pharmacycle.
• PharmacycleminorStrategic or Co-development PartnerPartnership with Pharmacycle for blister pack recycling initiative, demonstrating iNova's commitment to sustainability through responsible packaging disposal.
• White & Case LLPminorOthersWhite & Case LLP served as legal advisors for iNova's refinancing transaction, providing legal counsel on the financing structure.

Scale indicators3 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Haleon: London-listed global consumer healthcare pure-play (spun from GSK in 2022) with leading OTC brands across pain, oral health, vitamins and respiratory. Direct competitor to iNova in categories like sore throat, cough/cold and dermatology, and a credible exit acquirer for iNova.

Regional players

• Taisho Pharmaceutical: Japan-listed OTC and prescription pharmaceutical company with strong consumer health brands (Lipovitan, RiUP). Comparable as an Asia-focused branded OTC and prescription operator with regional brand portfolios.
• Aspen Pharmacare: South African pharmaceutical major with both branded consumer health and prescription portfolios across Africa. Comparable footprint, regulatory profile and OTC/prescription mix to iNova's South African business.
• Daewoong Pharmaceutical: South Korean pharmaceutical and consumer healthcare company with OTC, dermatology and prescription medicines. Comparable as a regional branded pharma operator with strong APAC and emerging-market presence.
• Adcock Ingram: South African-listed pharmaceutical and consumer health company. Direct peer in South Africa across OTC and prescription categories; iNova's Global Head of Medical Affairs Kym Hampton previously held senior roles at Adcock Ingram.

Broad incumbents

• Reckitt Benckiser: Global consumer health major with leading OTC brands (Strepsils, Nurofen, Gaviscon, Dettol). Strepsils is a direct competitor to Difflam in the sore throat category across APAC and the Middle East.
• Bayer Consumer Health: Bayer's consumer health unit with brands including Claritin, Aspirin, Canesten and Bepanthen. Competes with iNova across allergy, dermatology and wound care; Andrew Jenkin (iNova President CANZ & SA) previously held senior roles at Bayer.
• Kenvue: Johnson & Johnson's former consumer health division, now independent, with global OTC and personal care brands (Tylenol, Zyrtec, Neutrogena, Aveeno). Direct competitor to iNova in dermatology (DermaVeen vs. Aveeno) and OTC categories, and a likely strategic acquirer.
• Sanofi Consumer Healthcare: Global pharmaceutical major with a sizable consumer health division (Allegra, Dulcolax, Gold Bond). Competes with iNova in allergy (Demazin), laxatives (Senokot) and dermatology categories.

Others

• Mundipharma: Independent pharmaceutical network from which iNova acquired the BETADINE-anchored consumer health portfolio in 2024. Retained prescription and other operations make Mundipharma an adjacent ecosystem participant rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/inova-pharmaceuticals
• Xx.com/inovapharm
• Facebookfacebook.com/iNovaPharmaGlobal

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iNova Pharmaceuticals